ArticlePloS one2025

Impact of Chinese national centralized volume-based drug procurement policy on health costs and utilization: An interrupted time series analysis using panel data (2009-2022).

Yishi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.